Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 55.79%-131.56K | -56.59%-674.98K | 120.35%18.73K | -107.51%-268.96K | -49.72%-127.17K | -139.07%-297.59K | -0.42%-431.06K | 23.88%-92.04K | -7.54%-129.61K | 21.62%-84.94K |
| Net income from continuing operations | 19.03%-213.38K | -32.37%-587.36K | 269.86%73.41K | -60.12%-267.5K | -666.22%-129.72K | -21.72%-263.54K | 40.32%-443.72K | 78.89%-43.22K | -91.96%-167.06K | 94.02%-16.93K |
| Operating gains losses | ---- | 49.69%-43.75K | 99.11%-605 | --0 | ---- | ---- | ---86.96K | ---67.95K | ---12.73K | ---- |
| Depreciation and amortization | -19.21%5.91K | -54.69%21.61K | -141.04%-3K | 29.66%10.71K | -17.21%6.58K | -69.70%7.32K | -42.05%47.69K | -74.32%7.32K | -74.76%8.26K | -24.87%7.95K |
| Other non cashItems | -7.73%3.11K | -3.32%14.72K | 19.55%3.79K | -20.30%3.37K | 11.47%4.21K | -17.24%3.37K | -13.35%15.23K | -24.67%3.17K | -1.84%4.22K | -15.29%3.77K |
| Change In working capital | 262.75%72.8K | -318.52%-80.21K | -734.48%-54.86K | -141.19%-15.53K | 147.52%34.91K | -170.09%-44.73K | -82.88%36.71K | -82.94%8.65K | 153.46%37.7K | -145.86%-73.46K |
| -Change in receivables | -417.49%-154.09K | -428.31%-219.49K | -264.60%-123.51K | -572.45%-76.95K | 114.17%10.75K | -157.94%-29.78K | 170.02%66.86K | 391.99%75.04K | 147.22%16.29K | -369.53%-75.87K |
| -Change in inventory | -56.25%-26.25K | -71.72%15.09K | 235.53%47.15K | -276.57%-25.13K | 163.95%9.87K | -141.46%-16.8K | 183.59%53.35K | -0.73%14.05K | -52.26%14.23K | 75.73%-15.44K |
| -Change in prepaid assets | 35.02%-46.8K | -1,503.69%-23.03K | 120.80%61.19K | -311.07%-38.57K | -49.38%26.38K | 27.63%-72.03K | -168.32%-1.44K | 23.08%27.71K | -17.69%18.27K | 49.51%52.1K |
| -Change in payables and accrued expense | 479.14%245.64K | 979.01%162.35K | 113.29%12.55K | 382.70%108.16K | -103.99%-778 | 24.54%42.42K | -105.89%-18.47K | -292.35%-94.43K | 134.20%22.41K | -81.05%19.49K |
| -Change in other working capital | 72.61%54.3K | 76.20%-15.13K | -280.57%-52.23K | 150.60%16.95K | 78.95%-11.31K | -15.84%31.46K | -156.93%-63.6K | -46.14%-13.72K | -48.71%-33.5K | -192.78%-53.75K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 55.79%-131.56K | -56.59%-674.98K | 120.35%18.73K | -107.51%-268.96K | -49.72%-127.17K | -139.07%-297.59K | -0.42%-431.06K | 23.88%-92.04K | -7.54%-129.61K | 21.62%-84.94K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 360.84%213.79K | 275.77%179.44K | -108.03%-1.39K | 617.46%35.74K | 0 | -515.52%-81.96K | -25,421.00%-102.08K | 17.34K | 681.33%4.98K |
| Net PPE purchase and sale | --0 | -50.33%43.75K | -99.11%605 | --0 | 766.00%43.14K | --0 | 761.42%88.08K | 17,088.25%67.95K | --17.34K | 681.33%4.98K |
| Net investment purchase and sale | ---- | 200.00%170.04K | 205.17%178.83K | ---1.39K | ---- | ---- | ---170.04K | ---170.04K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 360.84%213.79K | 275.77%179.44K | -108.03%-1.39K | 617.46%35.74K | --0 | -515.52%-81.96K | -25,421.00%-102.08K | --17.34K | 681.33%4.98K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -31.57%152.89K | -32.16%394.07K | -122.23%-66.41K | 272.86%217.66K | -77.32%19.4K | 61.63%223.41K | 36.87%580.89K | 50.29%298.73K | 326.43%58.38K | -38.85%85.55K |
| Net issuance payments of debt | -175.90%-58.55K | 101.76%1.36K | -1,472.78%-92.5K | 197.87%94.76K | -569.99%-78.05K | 729.55%77.13K | 49.15%-76.8K | -118.54%-5.88K | 8.05%-96.83K | 186.28%16.61K |
| Net other financing activities | 44.54%211.44K | -40.29%392.71K | -91.44%26.09K | -20.82%122.89K | 41.33%97.45K | 13.46%146.28K | 14.29%657.69K | 51.20%304.62K | 95.16%155.2K | -56.68%68.95K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -31.57%152.89K | -32.16%394.07K | -122.23%-66.41K | 272.86%217.66K | -77.32%19.4K | 61.63%223.41K | 36.87%580.89K | 50.29%298.73K | 326.43%58.38K | -38.85%85.55K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.82%160.88K | 29.28%267.34K | -41.55%91.99K | -51.67%104.59K | 5.01%225.84K | 29.28%267.34K | -26.00%206.79K | -14.40%157.38K | -34.45%216.42K | -28.19%215.07K |
| Current changes in cash | 128.76%21.33K | -198.91%-67.13K | 25.94%131.76K | 2.23%-52.69K | -1,386.13%-72.02K | -742.30%-74.17K | 474.06%67.87K | 35.06%104.62K | 63.16%-53.89K | -81.74%5.6K |
| Effect of exchange rate changes | -56.85%14.1K | -437.11%-39.33K | -1,277.91%-62.87K | 879.47%40.09K | -1,059.97%-49.23K | 1,098.75%32.68K | 86.57%-7.32K | 109.79%5.34K | ---5.14K | ---4.24K |
| End cash Position | -13.08%196.31K | -39.82%160.88K | -39.82%160.88K | -41.55%91.99K | -51.67%104.59K | 5.01%225.84K | 29.28%267.34K | 29.28%267.34K | -14.40%157.38K | -34.45%216.42K |
| Free cash from | 55.79%-131.56K | -55.06%-674.98K | 120.35%18.73K | -106.32%-268.96K | -47.47%-127.17K | -134.92%-297.59K | 1.64%-435.3K | 23.88%-92.04K | -8.16%-130.36K | 21.34%-86.23K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.